RapidAI recently closed a $75 million Series C funding round led by Vista Credit Partners. The company offers an AI platform that helps hospital care teams triage and treat stroke patients more quickly.
Perspectum — a company that makes medical imaging devices designed to improve the diagnosis of metabolic diseases and cancer — recently announced the second close of its $55 million Series C funding round. Its flagship product is a diagnostic tool that assesses and monitors chronic liver disease.
Nuance recently added Baptist Health and Einstein Healthcare to its precision imaging network, a platform that allows healthcare providers to adopt AI-powered diagnostic imaging tools at the point of care. Joining the network means physicians will have an easier time quickly figuring out which tools make the biggest impact on patient care, Baptist’s chief medical information officer said.
Medical device manufacturer iCAD entered into a development and commercialization agreement with Google Health, in which it will integrate Google’s mammography AI technology into its suite of breast imaging AI products. The agreement marks Google’s first commercial partnership to deploy its breast imaging AI model into clinical practice.
GE Healthcare is preparing for its spinoff from GE, which is planned for the first week of January. The company’s split will allow it to operate under a new board, as well as manage its own capital. That capital will be primarily invested in acquisitions and research and development efforts, according to GE Healthcare's CEO for the U.S. and Canada.
Aidoc received authorization from the Food and Drug Administration to use its algorithms to detect likely Covid-19 cases in CT scans. The FDA issued guidelines allowing vendors with cleared triage solutions to expand their coverage to Covid-19.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
A retrospective study published in Nature shows Google’s DeepMind AI outperformed radiologists in detecting breast cancer. But it won’t be replacing them anytime soon.
Working together, vendors and facilities can establish strategies for gathering real-world evidence, including imaging and diverse data, successfully.
Touchstone Medical Imaging has agreed to pay $3 million to HHS' Office for Civil Rights to settle a breach that exposed more than 300,000 patients' protected health information.
Addressing issues like chronic pain, risk reporting and physician performance, here's a closer look at the companies in the fall 2018 class of Dreamit's HealthTech program.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
It's not the first time the German medical imaging and diagnostic business has made its intentions to file an IPO known, but perhaps the company is betting on a more receptive audience in the current market.
Through newly announced relationships with companies like Change Healthcare and Dicom Systems, Google Cloud is strengthening its influence in the medical imaging space.
Topping this year's list is ransomware and other cybersecurity threats. Contaminated mattresses, improperly cleaned medical devices and flaws in medical device networking also made the cut.
The South Florida group is applying Watson-powered "cognitive peer review" to medical imaging in an effort to diagnose aortic stenosis earlier.
Medstreaming, based in Redmond, Washington, disclosed the fundraise in an SEC Form D filing.
